NCT05667155View on ClinicalTrials.gov

Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

January 1, 2025

Study Completion Date

December 30, 2025

Conditions
B-cell Non Hodgkin Lymphoma
Interventions
BIOLOGICAL

CB dualCAR-NK19/70

Lentiviral vector-transducted cord blood-derived NK cells to express anti-CD19/CD70 CAR and IL15

Trial Locations (1)

310009

RECRUITING

2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hanzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER